Horizon Pharma (HZNP) Enters Settlement agreement with Express Scripts (ESRX); Will Pay $65M

Horizon Pharma (HZNP) Enters Rebate Agreement with Prime Therapeutics

Horizon Pharma plc (Nasdaq: HZNP) announced that it has entered into a rebate agreement with Prime Therapeutics, which secures formulary status for its primary care medicines. The rebate agreement begins on October 1, 2016.

Our philosophy is and will continue to be to ensure... More